The latest T1D content
Research that matters
Our daily questions
Continue with Google
Continue with Facebook
Meet the Expert: Evaluating Telemedicine in T1D Patient Care
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) was established in 2016 — with the support of The Leona M. and...
T1D Exchange Team: Our Type 1 Diabetes Diagnosis Stories
Nearly everyone on the staff at T1D Exchange is directly affected by type 1 diabetes (T1D) — living with it...
Total Transparency: How Cost Plus Drugs Sells Affordable Medications
Editor’s note: T1D Exchange has no active partnership with Cost Plus Drugs at the time of publication. T1D Exchange does...
All About the Medtronic Minimed 780G Closed-Loop Automated Insulin Pump System
Medtronic’s Minimed 780G hybrid closed-loop system received FDA approval on April 21, 2023, for use in people ages 7 and...
Meet the Expert: Improving the Transition from Pediatric to Adult Endocrinology in Type 1 Diabetes
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) was established in 2016 — with the support of The Leona M. and...
What I Wish Doctors Knew: Using Inhaled Insulin for Type 1 Diabetes
Editor’s Note: This article is based on Ginger’s personal experience using Afrezza inhaled insulin. Please consult your healthcare team before...
Meet the Expert: Asking the ‘Why?’ Behind Racial Disparities in Diabetes Tech Use
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) was established in 2016 — with the support of The Leona M. and...
Improving Diabetes Healthcare: Creating Space for Providers to Learn & Share
When healthcare providers from different clinics share and learn from each other, patients win. While we continue to see the...
Meet the Expert: Preventing Disease Complications By Addressing Health Equity
The T1D Exchange Quality Improvement Collaborative (T1DX-QI) was established in 2016 — with the support of The Leona M. and...
Promising Treatment for Recently Diagnosed Type 1 Diabetes Receives JDRF Funding
Diamyd Medical and JDRF recently announced a four-year research and development collaboration focused largely on the Phase 3 trial of...
